- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Vivimed Labs Limited — Important, 13-11-2025: Updates
13-11-2025 | 10:19 pm
13-11-2025 | 10:19 pm
Vivimed Labs' board approved filing for pre-packaged insolvency amid financial stress and expects trading suspension revocation. Q2 financial results show a ₹7.45 Cr standalone loss. Auditors qualified results due to unrecorded interest of ₹15.73 Cr, adjusting the loss to ₹23.17 Cr and significantly impacting net worth.
No comments yet. Be the first to comment!